Tandem Diabetes Care reports Q1 2024 results; specific figures not provided in filing text

TANDEM DIABETES CARE INC

2024-Q1 EPS reported -$0.65 revenue$191,674,000

Press release dated May 2, 2024 covers quarter ended March 31, 2024.
The 8-K body does not include financial data; full exhibit text was not available.
Investors should consult the actual press release for EPS, revenue, and guidance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.